XM无法为美国居民提供服务。
G
G

GoldmSachs


市场新闻

Goldman Sachs Selling Approximately 70 Million Shares Of Dr Martens Bookrunner

BRIEF-Goldman Sachs Selling Approximately 70 Million Shares Of Dr Martens PLC - Bookrunner Sept 19 (Reuters) - BLOCK TRADE: GOLDMAN SACHS SELLING APPROXIMATELY 70 MILLION SHARES OF DR MARTENS PLC; PRICE RANGE 57.7 PENCE TO MARKET - BOOKRUNNER Further company coverage: DOCS.L
G

Wall St gears up for rally after Fed kicks off easing cycle

US STOCKS-Wall St gears up for rally after Fed kicks off easing cycle For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. BofA expects Fed to go for 75-bp cut in Q4 US big banks rise after Fed's jumbo rate cut Weekly jobless claims stand at 219,000 Futures up: Dow 1.13%, S&P 500 1.58%, Nasdaq 2.14% Updated at 8:36 a.m.
B
C
G
G
I
J
M
N
A
U
U
U

BofA only top brokerage to raise forecast for Fed's 2024 rate cuts

CORRECTED-UPDATE 1-BofA only top brokerage to raise forecast for Fed's 2024 rate cuts Corrects paragraph 2 to say BofA expects 75 bps in cumulative rate cuts from the Fed in Q4, not a single rate cut; fixes typographical error in paragraph 7 By Kanchana Chakravarty Sept 19 (Reuters) - BofA Global Research was the only major brokerage to raise its forecast for the Federal Reserve's anticipated interest-rate cuts for the rest of 2024, a day after the U.S.
C
D
G

Futures jump as growth stocks lead gains after Fed cuts rates

US STOCKS-Futures jump as growth stocks lead gains after Fed cuts rates For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. BofA expects Fed to go for 75-bp cut in Q4 US big banks rise after Fed's jumbo rate cut Futures up: Dow 1.1%, S&P 500 1.6%, Nasdaq 2.07% Updated at 7:17 a.m. ET/1117 GMT By Johann M Cherian and Purvi Agarwal Sept 19 (Reuters) - U.S.
B
C
G
G
I
J
M
N
A
U
U
U

US bank stocks rise as jumbo rate cut eases credit risk, cost concerns

UPDATE 3-US bank stocks rise as jumbo rate cut eases credit risk, cost concerns Fed delivers 50-bp cut Lower rate expected to reduce deposit costs, aid borrowers - TransUnion Regional banks also see gains as investor jitters abate Recasts paragraph 1 & 2; updates prices throughout By Niket Nishant and Manya Saini Sept 19 (Reuters) - U.S. bank stocks rose on Thursday after the Federal Reserve's 50 basis point cut in interest rates raised hopes of lower deposit costs and reduced pressure on borrow
C
G
J
F
U

US bank stocks rise as jumbo rate cut eases default risk, cost concerns

US bank stocks rise as jumbo rate cut eases default risk, cost concerns Sept 19 (Reuters) - U.S. bank stocks rose in premarket trading on Thursday, a day after the Federal Reserve cut interest rates by 50 basis points, which is expected to reduce deposit costs and alleviate pressure on borrowers. Elevated interest rates have weighed on loan growth and consumer spending this year, while also increasing fears of borrowers defaulting on their loans.
C
G
J
F
U

BofA now expects Fed to go for 75 bps in rate cuts in Q4

CORRECTED-BofA now expects Fed to go for 75 bps in rate cuts in Q4 Corrects paragraph 3 and headline to say BofA expects 75 bps in cumulative rate cuts from the Fed in Q4, not a single rate cut Sept 19 (Reuters) - BofA Global Research raised its forecast for the Federal Reserve's anticipated interest rate cuts for the remainder of this year to 75 basis points, after the U.S.
G

Ascendis Pharma slips after $300 mln share offering launch

BUZZ-Ascendis Pharma slips after $300 mln share offering launch ** U.S.-listed shares of Ascendis Pharma ASND.O down 4.3% at $142.50 in extended trading as co seeks equity raise ** Denmark-based biopharma announces $300 mln offering of American depositary shares (ADSs) ** JP Morgan, Morgan Stanley, Evercore and Goldman Sachs are jt bookrunners ** On Mon, ASND shares closed up ~17% at $139.57 after co said its achondroplasia therapy TransCon CNP met main goal in trial to treat dwarfism ** Shares
B
G
J

Obesity drug developer BioAge seeks up to $587 mln valuation in US IPO

CORRECTED-UPDATE 2-Obesity drug developer BioAge seeks up to $587 mln valuation in US IPO Corrects bullet 2 and paragraph 5 to say drug is being tested along with GLP-1 treatments, not classified as a GLP-1 drug Healthcare firms perform well in subdued US IPO market in 2024 BioAge's azelaprag is being developed in combination with GLP-1 drugs Proceeds from IPO to advance azelaprag into late-stage studies Sept 18 (Reuters) - Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a v
C
G

US big banks rise after Fed cuts interest rates

BUZZ-US big banks rise after Fed cuts interest rates ** Economy-sensitive U.S. large-cap bank stocks rise in volatile afternoon trading after the U.S. Federal Reserve cuts benchmark interest rates by 50 basis points; KBW Banks Index .BKX up 0.8% ** JPMorgan Chase JPM.N , Wells Fargo WFC.N , Goldman Sachs GS.N , Morgan Stanley MS.N , Citigroup C.N and Bank of America BAC.N gain between 1% and 2.2% ** Rate cuts are expected to revitalize loan demand, deals activity and reduce unrealized losses on
C
G
J

Canada - Sept 18

PRESS DIGEST-Canada - Sept 18 Sept 18 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL - Justice Michael Penny, an Ontario Superior Court judge, has denied a request by ex-Dye & Durham Ltd. DND.TO chairman Tyler Proud to remove his nominee to the board, Edward Prittie, and replace him with hedge fund manager Eric Shahinian at upcoming special meeting.
G

Joe Biden’s climate law is too valuable to repeal

BREAKINGVIEWS-Joe Biden’s climate law is too valuable to repeal The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Gabriel Rubin WASHINGTON, Sept 18 (Reuters Breakingviews) - Rare is the politician who turns down an invitation to a ribbon-cutting ceremony, especially one that comes with the promise of hundreds of manufacturing jobs.
C
G
M
T

Reckitt rises after media report on early talks to sell homecare assets

BUZZ-Reckitt rises after media report on early talks to sell homecare assets ** Reckitt Benckiser RKT.L shares up 2% at 4,705p; stock top gainer on London's FTSE 100 index .FTSE and on the pan-European STOXX 600 .STOXX ** RKT at its highest level since March 15 ** Co has launched early discussions with potential suitors for a sale of its homecare a
G
U

Legal & General sells UK housebuilder CALA Group in $1.8 bln deal

UPDATE 2-Legal & General sells UK housebuilder CALA Group in $1.8 bln deal Updates after call with L&G CEO, adds shares and analyst comments By Sinead Cruise LONDON, Sept 18 (Reuters) - Legal & General LGEN.L has sold its UK housebuilder CALA Group in a deal worth 1.35 billion pounds ($1.78 billion) to an acquisition vehicle led by U.S. private assets firm Sixth Street Partners, as the latter steps up its European investment drive.
B
G
L

Iron ore slides on strong supply prospects, weak steel demand outlook

Iron ore slides on strong supply prospects, weak steel demand outlook SINGAPORE, Sept 18 (Reuters) - Iron ore futures prices slumped on Wednesday, as Chinese traders returned after the country's Mid-Autumn Festival holiday to a bleak market outlook for the key steelmaking ingredient, weighed down by prospects of firm supply and soft steel demand. The most-traded January iron ore contract on China's Dalian Commodity Exchange (DCE) DCIOcv1 ended morning trade 4.33% lower at 673.5 yuan ($94.91) a m
G

Goldman Sachs taps Drake-Brockman as CEO for Singapore business- Bloomberg News

MEDIA-Goldman Sachs taps Drake-Brockman as CEO for Singapore business- Bloomberg News -- Source link: https://tinyurl.com/2cnnro34 -- Note: Reuters has not verified this story and does not vouch for its accuracy
G

Hedge fund Irenic urges Canadian firm Kinaxis to run a strategic review

UPDATE 1-Hedge fund Irenic urges Canadian firm Kinaxis to run a strategic review Adds details on inbound interest, statement from company in paragraphs 5-6 By Svea Herbst-Bayliss NEW YORK, Sept 17 (Reuters) - Hedge fund Irenic Capital Management on Tuesday urged Kinaxis KXS.TO to see who may want to buy the Canadian software company and warned its board against making "reactive decisions" and taking "half measures." The board "should initiate a full strategic review including soliciting interest
G

Fed's close call - the waiting is almost over

MORNING BID ASIA-Fed's close call - the waiting is almost over By Jamie McGeever Sept 18 (Reuters) - A look at the day ahead in Asian markets. Investors in Asia will be forgiven for any reluctance to take on much risk on Wednesday ahead of the Federal Reserve 's interest rate decision later in the day, although rising expectations of a 50 basis point cut should provide some support to markets.
G
U
U

Hedge fund Irenic urges Kinaxis to run a strategic review,

Hedge fund Irenic urges Kinaxis to run a strategic review, NEW YORK, Sept 17 (Reuters) - Hedge fund Irenic Capital Management on Tuesday urged Kinaxis KXS.TO to see who may want to buy the Canadian software company and warned its board against making "reactive decisions" and taking "half measures." The Board "should initiate a full strategic review including soliciting interest for a sale for the whole company," Irenic said in a statement, echoing other investors' private and public calls for th
G

Reckitt starts talks on $7.9 bln homecare assets sale, Bloomberg News reports

UPDATE 2-Reckitt starts talks on $7.9 bln homecare assets sale, Bloomberg News reports Updates to add Reckitt's response in paragraph 4 Sept 17 (Reuters) - Reckitt Benckiser RKT.L has launched early discussions with potential suitors for a sale of its homecare assets, which could be worth over 6 billion pounds ($7.89 billion), Bloomberg News reported on Tuesday.
G



商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明